Antidepressant or antidepressant plus placebo effect?

World Psychiatry

Volumn 14, Issue 3, 2015, Pages 303-304

  Montgomery, Stuart A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; PLACEBO;

DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DSM-5; DSM-IV; HUMAN; META ANALYSIS (TOPIC); NOTE; PRIORITY JOURNAL; STUDY DESIGN;

EID: 84942524490     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20244     Document Type: Note

References (5)

1. Khan A, Brown WA., Antidepressants versus placebo in major depression: an overview. World Psychiatry 2015; 14: 294-300.
2. Khan A, Faucett J, Lichtenberg P, et al., A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 2012; 7: e41778.
3. Khan A, Redding N, Brown WA., The persistence of the placebo response in antidepressant clinical trials. J Psychiatr Res 2008; 42: 791-6.
4. Montgomery SA, Rasmussen JGC, Tanghoj P. A 24 week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 2008; 8: 181-8.
5. Frances AJ, Nardo JM., ICD-11 should not repeat the mistakes made by DSM-5. Br J Psychiatry 2013; 203: 1-2.